BF Biosciences Limited (PSX:BFBIO)

Pakistan flag Pakistan · Delayed Price · Currency is PKR
141.54
-4.82 (-3.29%)
At close: Apr 28, 2026
-6.67%
Market Cap 12.50B
Revenue (ttm) 8.22B
Net Income (ttm) 598.64M
Shares Out 88.33M
EPS (ttm) 6.78
PE Ratio 20.87
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 90,194
Average Volume 233,552
Open 145.00
Previous Close 146.36
Day's Range 141.13 - 146.00
52-Week Range 117.00 - 194.90
Beta n/a
RSI 46.27
Earnings Date Apr 27, 2026

About BF Biosciences

BF Biosciences Limited, a biotech pharmaceutical company, manufactures, imports, and sells pharmaceutical products in Pakistan, Nepal, Afghanistan, Mauritania, Switzerland, and internationally. The company offers pharmaceutical products for various therapeutic areas, including cardiometabolic disorders, cardiology, diabetes, anti-obesity, hepatology, gastroenterology, chronic kidney diseases, dermatology, antifungal treatments, antibiotics, antivirals, rheumatoid arthritis, nephrology, and oncology. It also provides injectables in vials, ampoul... [Read more]

Industry Pharmaceutical Preparations
Founded 2006
Employees 535
Stock Exchange Pakistan Stock Exchange
Ticker Symbol BFBIO
Full Company Profile

Financial Performance

In fiscal year 2025, BF Biosciences's revenue was 5.84 billion, an increase of 59.55% compared to the previous year's 3.66 billion. Earnings were 447.15 million, an increase of 16.02%.

Financial Statements

News

There is no news available yet.